SYRE

SYRE Change in Working Capital

-$5.01MTTM · USD

Period ending:

SYRE FY Change in Working CapitalUSD
SYRE FY Change in Working Capital2014-12-31: $26.00K2015-12-31: -$1.33M2016-12-31: $1.45M2017-12-31: -$198.00K2018-12-31: $7.20M2019-12-31: $7.10M2020-12-31: -$2.54M2021-12-31: $1.83M2022-12-31: -$5.50M2023-12-31: -$5.21M2024-12-31: -$4.53M2025-12-31: -$5.93M$7.20M-$5.93M
2014-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

SYRE change in working capital history

Working capital impact on cash flow. The available annual fiscal periods series contains 12 observations from Dec 31, 2014 to Dec 31, 2025.

Spyre Therapeutics Inc Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
-5,934,000
-4,534,000
-5,206,000
-5,503,000
1,833,000
-2,540,000
7,104,000
7,201,000
-198,000
1,450,000
-1,333,000
26,000

Compare change in working capital

All SYRE financial metrics · SYRE stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.